This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mahony, J. B.
Right arrow Articles by Petrich, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mahony, J. B.
Right arrow Articles by Petrich, A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, July 2000, p. 2622-2627, Vol. 38, No. 7
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Analytical Sensitivity, Reproducibility of Results, and Clinical Performance of Five PCR Assays for Detecting Chlamydia pneumoniae DNA in Peripheral Blood Mononuclear Cells

J. B. Mahony,1,2,* S. Chong,1 B. K. Coombes,1 M. Smieja,1 and A. Petrich1,2

Hamilton Regional Laboratory Medicine Program, St. Joseph's Hospital,1 and Department of Pathology and Molecular Medicine, McMaster University,2 Hamilton, Ontario, Canada

Received 18 January 2000/Returned for modification 31 March 2000/Accepted 4 May 2000

Chlamydia pneumoniae has been associated with atherosclerosis and coronary artery disease (CAD), and its DNA has been detected in atheromatous lesions of the aorta, carotid, and coronary arteries by a variety of PCR assays. The objective of this study was to compare the performances of five published PCR assays in the detection of C. pneumoniae in peripheral blood mononuclear cells (PBMCs) from patients with coronary artery disease. The assays included two conventional PCRs, one targeting a cloned PstI fragment and one targeting the 16S rRNA gene; two nested PCRs, one targeting the 16S rRNA gene and one targeting ompA; and a touchdown enzyme time release (TETR) PCR, targeting the 16S rRNA gene. All PCRs had similar analytical sensitivities and detected a minimum of 0.005 inclusion-forming units (IFU) of C. pneumoniae; the ompA nested PCR and the TETR PCR were slightly more sensitive and detected 0.001 IFU. Assay reproducibility was examined by testing 10 replicates of C. pneumoniae DNA by each assay. All five assays showed excellent reproducibility at high levels of DNA, with scores of 10 out of 10 for 0.01 IFU, but exhibited decreased reproducibility for smaller numbers of C. pneumoniae IFU for all tests. Pairwise comparison of test results indicated that there was a significant difference between tests (Cochran Q = 32.0, P < 0.001), with the PstI fragment (P < 0.001) and 16S rRNA (P = 0.002) assays having lower reproducibility than the nested ompA and TETR assays. To further analyze assay sensitivity, C. pneumoniae-infected U-937 mononuclear cells were added to whole blood, and extracted mononuclear-cell DNA was tested by each assay. All five assays showed similar sensitivities, detecting 15 infected cells; three assays detected 3 infected cells, while all assays were negative at the next dilution (1.5 infected cells). A striking difference in performance of the five assays was seen, however, when PBMCs from CAD patients were tested for C. pneumoniae DNA. The ompA nested PCR detected C. pneumoniae DNA in 11 of 148 (7.4%) specimens, the 16S rRNA nested PCR detected 2 positives among the 148 specimens (1.4%) (P < 0.001), and the other 3 assays detected no positive specimens (P < 0.001, compared with the ompA assay). These results indicate that analytical sensitivity alone does not predict the ability of an assay to detect C. pneumoniae in whole-blood-derived PBMCs. Before standardized assays can be used in wide-scale epidemiological studies, further characterization of these assays will be required to improve our understanding of their performance in the detection of C. pneumoniae in clinical material.

* Corresponding author. Mailing address: Regional Virology and Chlamydiology Laboratory, St. Joseph's Hospital, 50 Charlton Ave. E., Hamilton, Ontario L8N 4A6, Canada. Phone: (905) 521-6021. Fax: (905) 521-6083. E-mail: mahonyj{at}fhs.mcmaster.ca.

Journal of Clinical Microbiology, July 2000, p. 2622-2627, Vol. 38, No. 7
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Griffiths, E., Petrich, A. K., Gupta, R. S. (2005). Conserved indels in essential proteins that are distinctive characteristics of Chlamydiales and provide novel means for their identification. Microbiology 151: 2647-2657 [Abstract] [Full Text]  
  • Ginevra, C., Barranger, C., Ros, A., Mory, O., Stephan, J.-L., Freymuth, F., Joannes, M., Pozzetto, B., Grattard, F. (2005). Development and Evaluation of Chlamylege, a New Commercial Test Allowing Simultaneous Detection and Identification of Legionella, Chlamydophila pneumoniae, and Mycoplasma pneumoniae in Clinical Respiratory Specimens by Multiplex PCR. J. Clin. Microbiol. 43: 3247-3254 [Abstract] [Full Text]  
  • Apfalter, P., Barousch, W., Nehr, M., Willinger, B., Rotter, M., Hirschl, A. M. (2004). No Evidence of Involvement of Chlamydia pneumoniae in Severe Cerebrovascular Atherosclerosis by Means of Quantitative Real-Time Polymerase Chain Reaction. Stroke 35: 2024-2028 [Abstract] [Full Text]  
  • Contini, C, Cultrera, R, Seraceni, S, Castellazzi, M, Granieri, E, Fainardi, E (2004). Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis. Mult Scler 10: 360-369 [Abstract]  
  • Mukhopadhyay, S., Clark, A. P., Sullivan, E. D., Miller, R. D., Summersgill, J. T. (2004). Detailed Protocol for Purification of Chlamydia pneumoniae Elementary Bodies. J. Clin. Microbiol. 42: 3288-3290 [Abstract] [Full Text]  
  • Hardick, J., Maldeis, N., Theodore, M., Wood, B. J., Yang, S., Lin, S., Quinn, T., Gaydos, C. (2004). Real-Time PCR for Chlamydia pneumoniae Utilizing the Roche Lightcycler and a 16S rRNA Gene Target. J. Mol. Diagn. 6: 132-136 [Abstract] [Full Text]  
  • Cagli, S, Oktar, N, Dalbasti, T, Erensoy, S, Ozdamar, N, Goksel, S, Sayiner, A, Bilgic, A (2003). Failure to detect Chlamydia pneumoniae DNA in cerebral aneursymal sac tissue with two different polymerase chain reaction methods. J. Neurol. Neurosurg. Psychiatry 74: 756-759 [Abstract] [Full Text]  
  • Cochrane, M., Pospischil, A., Walker, P., Gibbs, H., Timms, P. (2003). Distribution of Chlamydia pneumoniae DNA in Atherosclerotic Carotid Arteries: Significance for Sampling Procedures. J. Clin. Microbiol. 41: 1454-1457 [Abstract] [Full Text]  
  • Higgins, J. P. (2003). Chlamydia pneumoniae and Coronary Artery Disease: The Antibiotic Trials. Mayo Clin Proc. 78: 321-332 [Abstract]  
  • Apfalter, P., Barousch, W., Nehr, M., Makristathis, A., Willinger, B., Rotter, M., Hirschl, A. M. (2003). Comparison of a New Quantitative ompA-Based Real-Time PCR TaqMan Assay for Detection of Chlamydia pneumoniae DNA in Respiratory Specimens with Four Conventional PCR Assays. J. Clin. Microbiol. 41: 592-600 [Abstract] [Full Text]  
  • Kalayoglu, M. V., Libby, P., Byrne, G. I. (2002). Chlamydia pneumoniae as an Emerging Risk Factor in Cardiovascular Disease. JAMA 288: 2724-2731 [Abstract] [Full Text]  
  • Chernesky, M., Smieja, M., Schachter, J., Summersgill, J., Schindler, L., Solomon, N., Campbell, K., Campbell, L., Cappuccio, A., Gaydos, C., Chong, S., Moncada, J., Phillips, J., Jang, D., Wood, B. J., Petrich, A., Hammerschlag, M., Cerney, M., Mahony, J. (2002). Comparison of an Industry-Derived LCx Chlamydia pneumoniae PCR Research Kit to In-House Assays Performed in Five Laboratories. J. Clin. Microbiol. 40: 2357-2362 [Abstract] [Full Text]  
  • Hermann, C., Graf, K., Groh, A., Straube, E., Hartung, T. (2002). Comparison of Eleven Commercial Tests for Chlamydia pneumoniae-Specific Immunoglobulin G in Asymptomatic Healthy Individuals. J. Clin. Microbiol. 40: 1603-1609 [Abstract] [Full Text]  
  • Tondella, M. L. C., Talkington, D. F., Holloway, B. P., Dowell, S. F., Cowley, K., Soriano-Gabarro, M., Elkind, M. S., Fields, B. S. (2002). Development and Evaluation of Real-Time PCR-Based Fluorescence Assays for Detection of Chlamydiapneumoniae. J. Clin. Microbiol. 40: 575-583 [Abstract] [Full Text]  
  • Ikejima, H., Haranaga, S., Takemura, H., Kamo, T., Takahashi, Y., Friedman, H., Yamamoto, Y. (2001). PCR-Based Method for Isolation and Detection of Chlamydia pneumoniae DNA in Cerebrospinal Fluids. CVI 8: 499-502 [Abstract] [Full Text]  
  • Smieja, M., Mahony, J. B., Goldsmith, C. H., Chong, S., Petrich, A., Chernesky, M. (2001). Replicate PCR Testing and Probit Analysis for Detection and Quantitation of Chlamydia pneumoniae in Clinical Specimens. J. Clin. Microbiol. 39: 1796-1801 [Abstract] [Full Text]  
  • Smieja, M., Chong, S., Natarajan, M., Petrich, A., Rainen, L., Mahony, J. B. (2001). Circulating Nucleic Acids of Chlamydia pneumoniae and Cytomegalovirus in Patients Undergoing Coronary Angiography. J. Clin. Microbiol. 39: 596-600 [Abstract] [Full Text]  
  • Hammerschlag, M. R., Ke, Z., Lu, F., Roblin, P., Boman, J., Kalman, B. (2000). Is Chlamydia pneumoniae Present in Brain Lesions of Patients with Multiple Sclerosis?. J. Clin. Microbiol. 38: 4274-4276 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»